A Joint Research Team from the Kerbala University and Kufa Obtains a Patent for the Removing of high creatinine levels in blood plasma

A joint research team from the Universities of Kerbala and Kufa has obtained a patent from the Central Organization for Standardization and Quality Control (COSQC) of the Ministry of Planning, entitled “Removing the high creatinine ratio in blood plasma using nanoparticles of zinc oxide.”
The patent aims at identifying ways of removing high creatinine levels from blood plasma using modern methods.
The patent includes identifying the removal of high creatinine levels in the blood plasma by using nanoparticles of zinc oxide. It also deals with the negative effects of creatinine on human health, its causes, and the importance of getting rid of it.
The team consists of Dr. Hamida Idan Salman, Dean of the Faculty of Education for Pure Sciences, University of Kerbala, Dr. Hana Aday Ali – Faculty of Science, University of Kufa, and researcher Mays Ahmed Kadhim, University of Kerbala/Faculty of Education for Pure Sciences/Department of Chemistry.